Hox Therapeutics
Guildford
About Hox Therapeutics
HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology Department to develop new therapeutics for cancer, based on the role of HOX genes in cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: Seed
- Last round: Seed (Sep 2016)
- Website: hoxtherapeutics.com
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/hox-therapeutics-185455 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.